CNBC's Oliver Renick reports on the latest action in options markets. Got a confidential news tip? We want to hear from you.
Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...
The trustees voted while dozens of people in the audience held signs and at times called out their opposition to the move.
Popular chatbots exhibit a liberal bias in their responses to political questions, a new analysis from The Washington Post ...
Small businesses are collecting tons of data, but they need to transform it to make better business decisions.
AI Assistant AI Agents Autonomous AI Agentic AI Workplace Automation Business Productivity Productivity Tools AI for Work ...
A new analysis from The Washington Post found popular chatbots exhibit a liberal bias in their responses to political ...
MicroStrategy stock trades below the value of its own Bitcoin near $104, yet money flow shows big buyers still refuse to step ...
A new study found that people using weight-loss drugs are doing less exercise, despite feeling healthier. Here's how muscle ...
Collaboration combines Saudi Arabia's national health data capabilities with Flagship's life sciences and AI-enabled ...
There is a better way: an e-commerce customer support platform that uses both AI and human customer service. This hybrid AI ...
That advantage now shows up across the parts of a company that usually need headcount first: documentation, product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results